Author of the publication

Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

, , , , , , , , , , , , , , , , , , , , , and . Lancet Healthy Longev., 3 (6): e417--e427 (June 2022)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Bolling, Claus
add a person with the name Bolling, Claus
 

Other publications of authors with the same name